PDI, Inc.(Nasdaq: PDII) reported that as the Company transitions to focusing solely on its molecular diagnostics operations, Nancy Lurker has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE